266 related articles for article (PubMed ID: 36517035)
21. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
[TBL] [Abstract][Full Text] [Related]
22. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
[TBL] [Abstract][Full Text] [Related]
23. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.
Huang X; Xu M; Chen Y; Peng K; Huang Y; Wang P; Ding L; Lin L; Xu Y; Chen Y; Lu J; Wang W; Bi Y; Ning G
Medicine (Baltimore); 2015 Oct; 94(40):e1682. PubMed ID: 26448014
[TBL] [Abstract][Full Text] [Related]
24. Obesity- and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study.
Gui J; Li Y; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
Front Public Health; 2023; 11():1073824. PubMed ID: 36875382
[TBL] [Abstract][Full Text] [Related]
25. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
[TBL] [Abstract][Full Text] [Related]
26. Association between triglyceride glucose-related markers and the risk of metabolic-associated fatty liver disease: a cross-sectional study in healthy Chinese participants.
Chang M; Shao Z; Shen G
BMJ Open; 2023 May; 13(5):e070189. PubMed ID: 37130686
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the Triglyceride Glucose Index and Modified Triglyceride Glucose Indices to Predict Nonalcoholic Fatty Liver Disease in Youths.
Song K; Park G; Lee HS; Lee M; Lee HI; Choi HS; Suh J; Kwon A; Kim HS; Chae HW
J Pediatr; 2022 Mar; 242():79-85.e1. PubMed ID: 34808224
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the predictive power of adiposity indices and blood lipid indices for diagnosis of prediabetes.
Zhang Y; Wang M; Zuo Y; Su X; Wen J; Zhai Q; He Y
Hormones (Athens); 2022 Dec; 21(4):683-690. PubMed ID: 36166170
[TBL] [Abstract][Full Text] [Related]
29. Triglyceride Glucose Index is Associated with Ultrasonographic Fatty Liver Indicator in Children and Adolescents with Non-alcoholic Fatty Liver Disease.
Kim B; Jin HY; Yoon JS; Noh ES; Hwang IT
J Clin Res Pediatr Endocrinol; 2024 Apr; ():. PubMed ID: 38664989
[TBL] [Abstract][Full Text] [Related]
30. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
31. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
[No Abstract] [Full Text] [Related]
32. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
[TBL] [Abstract][Full Text] [Related]
33. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the diagnostic performance of twelve noninvasive scores of metabolic dysfunction-associated fatty liver disease.
Zou H; Ma X; Zhang F; Xie Y
Lipids Health Dis; 2023 Sep; 22(1):145. PubMed ID: 37674196
[TBL] [Abstract][Full Text] [Related]
35. A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.
Chen LW; Huang PR; Chien CH; Lin CL; Chien RN
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):173-181. PubMed ID: 30981560
[TBL] [Abstract][Full Text] [Related]
36. Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study.
Li Y; Gui J; Zhang X; Wang Y; Mei Y; Yang X; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
BMC Cardiovasc Disord; 2023 Apr; 23(1):201. PubMed ID: 37081416
[TBL] [Abstract][Full Text] [Related]
37. Validation of the Fatty Liver Index for identifying non-alcoholic fatty liver disease in a Kenyan population.
Lajeunesse-Trempe F; Boit MK; Kaduka LU; De Lucia-Rolfe E; Baass A; Paquette M; Piché ME; Tchernof A; Christensen DL
Trop Med Int Health; 2023 Oct; 28(10):830-838. PubMed ID: 37650501
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort.
Zeng J; Jin Q; Yang J; Yang RX; Zhang RN; Zhao J; Fan JG
Hepatol Int; 2023 Dec; 17(6):1416-1428. PubMed ID: 37728728
[TBL] [Abstract][Full Text] [Related]
39. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease.
Zaki M; Amin D; Mohamed R
J Complement Integr Med; 2020 Dec; 18(2):385-390. PubMed ID: 34187121
[TBL] [Abstract][Full Text] [Related]
40. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
